The TRIUMPH Program in One Paragraph TRIUMPH is Eli Lilly's name for the Phase 3 program of retatrutide (LY3437943) a triple agonist of the GLP-1, GIP, and glucagon receptors
All this said, remember to consult your healthcare provider if you have any questions about adjusting your tirzepatide dosing schedule
Capsaicin from chili peppers may have a mild appetite effect for some individuals
S., Pduraru, L., Yahya, G., Metwally, K., & Cavalu, S
hypertension, type 2 DM, dyslipidemia) A meta-analysis of 22 trials involving over 17,000 patients determined that 50.2% and 17.5% of patients treated with GLP-1RAs (exenatide, semaglutide & liraglutide) experienced a weight loss of 5% and 10% compared to placebo, and that patients without type 2 diabetes achieved a significantly greater weight loss compared to those with diabetes (Vosoughi et al, 2022)